board certified psychiatrists
Each Actify office is led by one or more board-certified psychiatrists. Our teams are also comprised of Advanced Practice Nurses that are board-certified in psychiatry, experienced RN-level infusion nurses, and additional nursing and support staff. All medical personnel are trained in advanced cardiac life support (ACLS) to ensure patient safety.READ MORE
how we collaborate with you
Our Actify teams serve as consultants to you, the primary provider of mental health treatment for your patients. We want to learn from you, and in turn, serve as a resource for cutting-edge treatments that complement your care. We will confirm with you that your patient is actively under your care, provide a full consultation to gather history, confirmREAD MORE
Providing hope and innovation, with nine locations and a growing presence in the mental health community, Actify Neurotherapies is the leading advanced mental health treatment practice in the country. Our ketamine specialists have treated thousands of patients since 2011 using industry leading methods and technology to achieve optimal results.READ MORE
Actify takes patient selection seriously. To ensure that we are consulting with appropriate patients who may benefit from our services, our Patient Services Specialists screen all prospective patients for appropriate indications for treatment, contraindications for treatment, and medical status. Candidate patients are then scheduled for in-office comprehensive consultations with our board-certified psychiatrists.VIEW MORE STORIES
- Major Depression
- Post-traumatic Stress Disorder
- Bipolar Depression
- Severe Anxiety
- Fibromyalgia and Pain Syndromes
- Obsessive Compulsive Disorder
Conditions We Treat
We provide evidence-based ketamine infusion therapy to treat these conditions.
Our on-site psychiatrists will consult with you at in-take and at the end of each session, Depression and anxiety scale scores are measured at every session to monitor progress response or relapse.
Science Focused. Data Driven.
“Recent data suggest that Ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades.”
-Thomas Insel, Former Director of the National Institute of Mental Health